Djupesland, P., & Dočekal, P. (2010). Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study. Cephalalgia, 30(8), 933-942. https://doi.org/10.1177/0333102409359314
Chicago Style (17th ed.) CitationDjupesland, PG, and P. Dočekal. "Intranasal Sumatriptan Powder Delivered by a Novel Breath-actuated Bi-directional Device for the Acute Treatment of Migraine: A Randomised, Placebo-controlled Study." Cephalalgia 30, no. 8 (2010): 933-942. https://doi.org/10.1177/0333102409359314.
MLA (9th ed.) CitationDjupesland, PG, and P. Dočekal. "Intranasal Sumatriptan Powder Delivered by a Novel Breath-actuated Bi-directional Device for the Acute Treatment of Migraine: A Randomised, Placebo-controlled Study." Cephalalgia, vol. 30, no. 8, 2010, pp. 933-942, https://doi.org/10.1177/0333102409359314.